col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


101 Results       Page 1

 [1] 
Springer-Verlag: Journal of Clinical Immunology
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―21 Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19 Hakim Hocini, Aurélie Wiedemann, Fabiola Blengio, Cécile Lefebvre, Minerva Cervantes-Gonzalez, Emile Foucat, et al. (+82)
2 [GO] 2023―Mar―17 Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination Sophie Steiner, Tatjana Schwarz, Victor M. Corman, Lara M. Jeworowski, Sandra Bauer, Christian Drosten, et al. (+2)
3 [GO] 2023―Mar―02 Efficacy of Tixagevimab and Cilgavimab Against SARS-CoV-2 Infections in Patients with Inborn Errors of Immunity Sarah Johnson, John C. McDonnell, James M. Fernandez
4 [GO] 2023―Feb―21 Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children Jianguo Zhou, Xiang Chen, Yanming Lu, Libo Wang, Hui Yu
5 [GO] 2023―Feb―16 COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity Laura Gragnani, Marcella Visentini, Serena Lorini, Stefano Angelo Santini, Gianfranco Lauletta, Cesare Mazzaro, et al. (+25)
6 [GO] 2022―Nov―28 Macrophage Activation Syndrome Complicated by Toxic Epidermal Necrolysis Following SARS-CoV-2 mRNA Vaccination Lauren E. Franzblau, Melissa Mauskar, Christian A. Wysocki
7 [GO] 2022―Nov―14 Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study Cinzia Milito, Francesco Cinetto, Giulia Garzi, Andrea Palladino, Marco Puca, Elena Brambilla, et al. (+9)
8 [GO] 2022―Nov―04 Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients Takeshi Ebihara, Tsunehiro Matsubara, Yuki Togami, Hisatake Matsumoto, Jotaro Tachino, Hiroshi Matsuura, et al. (+6)
9 [GO] 2022―Oct―17 COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity Lorenzo Erra, Ignacio Uriarte, Ana Colado, María Virginia Paolini, Gisela Seminario, Julieta Belén Fernández, et al. (+23)
10 [GO] 2022―Oct―07 Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis Alexandre Bolze, Trine H. Mogensen, Shen-Ying Zhang, Laurent Abel, Evangelos Andreakos, Lisa M. Arkin, et al. (+89)
11 [GO] 2022―Sep―23 Immune Response to SARS-CoV-2 Infections in Children with Secondary Immunodeficiencies Karolina Kuczborska, Ewelina Krzemińska, Piotr Buda, Edyta Heropolitańska-Pliszka, Barbara Piątosa, Janusz Książyk
12 [GO] 2022―Sep―19 Long-Term Antibody Response to SARS-CoV-2 in Children Gabor A. Dunay, Madalena Barroso, Mathias Woidy, Marta K. Danecka, Geraldine Engels, Katharina Hermann, et al. (+98)
13 [GO] 2022―Aug―25 Myocarditis in 13-Year-Old Monochorionic Diamniotic Twins After COVID-19 Vaccination Hayato Nishibayashi, Shintaro Kishimoto, Kazuhito Sekiguchi, Satoshi Okada, Kenji Ihara
14 [GO] 2022―Aug―25 Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants Manon Vogrig, Anne-Emmanuelle Berger, Thomas Bourlet, Louis Waeckel, Alice Haccourt, Alice Chanavat, et al. (+5)
15 [GO] 2022―Aug―17 Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program Carla Toledo-Salinas, Selma Cecilia Scheffler-Mendoza, Lina Maria Castano-Jaramillo, José Antonio Ortega-Martell, Blanca Estela Del Rio-Navarro, Ana María Santibáñez-Copado, et al. (+7)
16 [GO] 2022―Jul―09 Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization Giulia Lamacchia, Alessio Mazzoni, Michele Spinicci, Anna Vanni, Lorenzo Salvati, Benedetta Peruzzi, et al. (+17)
17 [GO] 2022―Jul―02 Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications Michele Spinicci, Alessio Mazzoni, Marco Coppi, Alberto Antonelli, Lorenzo Salvati, Laura Maggi, et al. (+14)
18 [GO] 2022―Jun―29 Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19 Shohei Eto, Yoko Nukui, Miyuki Tsumura, Yu Nakagama, Kenichi Kashimada, Yoko Mizoguchi, et al. (+24)
19 [GO] 2022―Jun―17 Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency Junghee Jenny Shin, Jennefer Par-Young, Serhan Unlu, Andrew McNamara, Hong-Jai Park, Min Sun Shin, et al. (+13)
20 [GO] 2022―Jun―08 Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia Angélique Chauvineau-Grenier, Paul Bastard, Jean-Laurent Casanova, Benjamin Rossi
21 [GO] 2022―May―11 Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant Hannes Lindahl, Jonas Klingström, Rui Da Silva Rodrigues, Wanda Christ, Puran Chen, Hans-Gustaf Ljunggren, et al. (+4)
22 [GO] 2022―May―05 Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies Bengisu Akbil, Tim Meyer, Paula Stubbemann, Charlotte Thibeault, Olga Staudacher, Daniela Niemeyer, et al. (+33)
23 [GO] 2022―Apr―20 The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) Giuliana Giardino, Cinzia Milito, Vassilios Lougaris, Alessandra Punziano, Maria Carrabba, Francesco Cinetto, et al. (+25)
24 [GO] 2022―Apr―14 SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study Adrian M. Shields, Sian E. Faustini, Harriet J. Hill, Saly Al-Taei, Chloe Tanner, Fiona Ashford, et al. (+52)
25 [GO] 2022―Apr―02 SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine Sudhir Gupta, Sudhanshu Agrawal, Ashley Sandoval, Houfen Su, Michelle Tran, Yesim Demirdag
26 [GO] 2022―Mar―30 Correction to: Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome Daigo Akahane, Shunsuke Otsuki, Daisuke Hasegawa, Hidehiro Watanabe, Akihiko Gotoh
27 [GO] 2022―Mar―25 Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia Maria Carrabba, Lucia Augusta Baselli, Dario Consonni, Ferruccio Ceriotti, Giovanna Fabio
28 [GO] 2022―Mar―19 Diagnosis of APS-1 in Two Siblings Following Life-Threatening COVID-19 Pneumonia Laire Schidlowski, Ana Paula Diniz Iwamura, Laurent Abel, Paul Bastard, Jacinta Bustamante, Jean-Laurent Casanova, et al. (+6)
29 [GO] 2022―Mar―18 22q11.2 Deletion and Duplication Syndromes and COVID-19 T. Blaine Crowley, Donna McDonald McGinn, Kathleen E. Sullivan, Caterina Cancrini, Andrew Gennery, Dinakantha Kumararatne, et al. (+5)
30 [GO] 2022―Mar―17 Transient Increase of Pre-existing Anti-IFN-α2 Antibodies Induced by SARS-CoV-2 Infection Sophie Steels, Jan Van Elslande, Maaike Cockx, Glynis Frans, Maya Imbrechts, Doreen Dillaerts, et al. (+7)
31 [GO] 2022―Mar―15 Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency Peter Bergman, David Wullimann, Yu Gao, Emilie Wahren Borgström, Anna-Carin Norlin, Sara Lind Enoksson, et al. (+4)
32 [GO] 2022―Mar―03 Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality Jesús Troya, Paul Bastard, Jean-Laurent Casanova, Laurent Abel, Aurora Pujol
33 [GO] 2022―Feb―17 First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis Nicholas G. Kounis, Ioanna Koniari, Virginia Mplani, Panagiotis Plotas, Grigorios Tsigkas
34 [GO] 2022―Feb―11 COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort Mark J. Ponsford, Kimberly Evans, Emily M. Carne, Stephen Jolles, Kathryn Bramhall, Leanne Grant, et al. (+9)
35 [GO] 2022―Jan―28 Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome Hassan Abolhassani, Nils Landegren, Paul Bastard, Marie Materna, Mohammadreza Modaresi, Likun Du, et al. (+18)
36 [GO] 2022―Jan―27 Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French Hospital Angélique Chauvineau-Grenier, Paul Bastard, Antoine Servajean, Adrian Gervais, Jérémie Rosain, Emmanuelle Jouanguy, et al. (+3)
37 [GO] 2022―Jan―09 Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization Stefania Dispinseri, Ilaria Marzinotto, Cristina Brigatti, Maria Franca Pirillo, Monica Tolazzi, Elena Bazzigaluppi, et al. (+13)
38 [GO] 2022―Jan―03 First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction Rohan Ameratunga, See-Tarn Woon, Mary N. Sheppard, Jack Garland, Benjamin Ondruschka, Christopher X. Wong, et al. (+4)
39 [GO] 2021―Dec―10 Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency Julia Lang-Meli, Jonas Fuchs, Philipp Mathé, Hsi-en Ho, Lisa Kern, Lena Jaki, et al. (+14)
40 [GO] 2021―Dec―01 Dexamethasone Treatment for COVID-19-Related Lung Injury in an Adult with WHIM Syndrome Daigo Akahane, Shunsuke Otsuki, Daisuke Hasegwa, Hidehiro Watanabe, Akihiko Gotoh
41 [GO] 2021―Nov―27 Correction to: Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, Yun Shan Goh, Siti Naqiah Amrun, Nicholas Ang, et al. (+20)
42 [GO] 2021―Nov―12 Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19 Matthijs P. Raadsen, Arvind Gharbharan, Carlijn C. E. Jordans, Anna Z. Mykytyn, Mart M. Lamers, Petra B. van den Doel, et al. (+9)
43 [GO] 2021―Oct―31 Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients Marketa Bloomfield, Zuzana Parackova, Jana Hanzlikova, Jan Lastovicka, Anna Sediva
44 [GO] 2021―Oct―30 Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection Siew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, Yun Shan Goh, Siti Naqiah Amrun, Nicholas Ang, et al. (+20)
45 [GO] 2021―Oct―29 Persistent COVID-19 Infection in Wiskott-Aldrich Syndrome Cleared Following Therapeutic Vaccination: a Case Report Rachel E. Bradley, Mark J. Ponsford, Martin J. Scurr, Andrew Godkin, Stephen Jolles, Kathryn Bramhall, et al. (+5)
46 [GO] 2021―Oct―28 A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19 Shaghayegh Khanmohammadi, Nima Rezaei, Mehdi Khazaei, Afshin Shirkani
47 [GO] 2021―Oct―25 COVID-19 in CVID: a Case Series of 17 Patients Jacob R. Greenmyer, Avni Y. Joshi
48 [GO] 2021―Oct―25 Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group Maral Barzegar-Amini, Mahmoud Mahmoudi, Maliheh Dadgarmoghaddam, Faramarz Farzad, Ali Qaraee Najafabadi, Farahzad Jabbari-Azad
49 [GO] 2021―Oct―20 SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best Ane Fernandez Salinas, Eva Piano Mortari, Sara Terreri, Concetta Quintarelli, Federica Pulvirenti, Stefano Di Cecca, et al. (+13)
50 [GO] 2021―Oct―08 Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, Vincent Bondet, Cyril Gitiaux, Julie Bonigen, et al. (+10)
51 [GO] 2021―Sep―28 Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms Diem-Lan Vu, Paola Martinez-Murillo, Fiona Pigny, Maria Vono, Benjamin Meyer, Christiane S. Eberhardt, et al. (+8)
52 [GO] 2021―Sep―27 Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona Xavier Solanich, Raúl Rigo-Bonnin, Victor-David Gumucio, Paul Bastard, Jérémie Rosain, Quentin Philippot, et al. (+17)
53 [GO] 2021―Sep―15 Prolonged Fecal Shedding of SARS-CoV-2 in Asymptomatic Children with Inborn Errors of Immunity Madhu Chhanda Mohanty, Prasad D. Taur, Unnati Prashant Sawant, Reetika Malik Yadav, Varsha Potdar
54 [GO] 2021―Aug―23 Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection Mathieu Paul Rodero, Stéphane Pelleau, Anne Welfringer-Morin, Darragh Duffy, Isabelle Melki, Brigitte Bader-Meunier, et al. (+10)
55 [GO] 2021―Aug―21 Self-Limited COVID-19 in a Patient with Artemis Hypomorphic SCID Stanislaw J. Gabryszewski, Ross N. England, Di Sun, Tatiana Londoño Gentile, William Hochgertel, Soma Jyonouchi, et al. (+4)
56 [GO] 2021―Jul―26 Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection? Mark Kacar, Paulina Cortes-Acevedo, Vinesh Patel, Clive Carter, Pamela Hughes, Hugh P. McGann, et al. (+5)
57 [GO] 2021―Jul―21 Safety of COVID-19 Vaccination in Immune-Deficient Patients Receiving Supplemental Immunoglobulin Therapies Jacqueline D. Squire, Avni Y. Joshi
58 [GO] 2021―Jul―17 Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study Javier García-Abellán, Sergio Padilla, Marta Fernández-González, José A. García, Vanesa Agulló, María Andreo, et al. (+4)
59 [GO] 2021―Jul―15 Containment of Local COVID-19 Outbreak Among Hematopoietic Stem Cell Transplant Recipients and Healthcare Workers in a Pediatric Stem Cell Unit Monia Ouederni, Samia Rekaya, Oussema Boꯚllah, Ilhem Ben Fradj, Ridha Kouki, Yosr Chebbi, et al. (+11)
60 [GO] 2021―Jul―07 Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality Maaweya E. Hamed, Asif Naeem, Haitham Alkadi, Aref A. Alamri, Ahmad S. AlYami, Abdullah AlJuryyan, et al. (+5)
61 [GO] 2021―Jul―06 COVID-19 in Patients with Primary Immunodeficiency Saliha Esenboga, Melike Ocak, Ayşegul Akarsu, Hacer Neslihan Bildik, Deniz Cagdas, Arzu Topeli Iskit, Ilhan Tezcan
62 [GO] 2021―Jun―26 SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist Alizée Bozonnat, Florence Assan, Jérôme LeGoff, Emmanuelle Bourrat, Hervé Bachelez
63 [GO] 2021―Jun―25 SARS-CoV-2-Related Acute Respiratory Distress Syndrome Uncovers a Patient with Severe Combined Immunodeficiency Disease Bandar Al-Saud, Khaled M. Hazzazi, Reem Mohammed, Alaa Al Najjar, Tariq Al Hazmi, Dorota Monies, Fowzan S. Alkuraya
64 [GO] 2021―Jun―23 Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study Ekaterini Simões Goudouris, Fernanda Pinto-Mariz, Leonardo Oliveira Mendonça, Carolina Sanchez Aranda, Rafaela Rolla Guimarães, Cristina Kokron, et al. (+33)
65 [GO] 2021―Jun―10 COVID-19 in the Context of Inborn Errors of Immunity: a Case Series of 31 Patients from Mexico Lina M. Castano-Jaramillo, Marco Antonio Yamazaki-Nakashimada, Patricia M. O’Farrill-Romanillos, David Muzquiz Zermeño, Selma C. Scheffler Mendoza, Edna Venegas Montoya, et al. (+14)
66 [GO] 2021―Jun―09 SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance? Paloma Guisado Hernández, Pilar Blanco Lobo, Isabel Villaoslada, Beatriz de Felipe, José M. Lucena, Guillermo Martín Gutierrez, et al. (+6)
67 [GO] 2021―Jun―08 Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β Donald C. Vinh, Laurent Abel, Paul Bastard, Matthew P. Cheng, Antonio Condino-Neto, Peter K. Gregersen, et al. (+28)
68 [GO] 2021―Jun―05 Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome Louise Malle, Paul Bastard, Andrea Martin-Nalda, Taya Carpenter, Douglas Bush, Roosheel Patel, et al. (+6)
69 [GO] 2021―May―29 MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population Shay Ben Shachar, Noam Barda, Sigal Manor, Sapir Israeli, Noa Dagan, Shai Carmi, et al. (+3)
70 [GO] 2021―May―19 Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma Sara E. Vazquez, Paul Bastard, Kathleen Kelly, Adrian Gervais, Philip J. Norris, Larry J. Dumont, et al. (+3)
71 [GO] 2021―May―13 Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency Hannah Kinoshita, Jessica Durkee-Shock, Mariah Jensen-Wachspress, Vaishnavi V. Kankate, Haili Lang, Christopher A. Lazarski, et al. (+10)
72 [GO] 2021―May―05 Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia Che-Mai Chang, Po-Hao Feng, Tsung-Hsun Wu, Houda Alachkar, Kang-Yun Lee, Wei-Chiao Chang
73 [GO] 2021―May―03 SARS-CoV-2 Infection in a Child with Severe Congenital Neutropenia Pandiarajan Vignesh, Sanjib Mondal, Murugan Sudhakar, Yogish Kumar Sharma, Arun Bansal, Mini Singh, Man Updesh Singh Sachdeva
74 [GO] 2021―Apr―16 Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets George P. Drewett, Ana Copaescu, Effie Mouhtouris, Natalie Hannan, Fiona James, Olivia Smibert, et al. (+2)
75 [GO] 2021―Apr―13 Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain Jesús Troya, Paul Bastard, Laura Planas-Serra, Pablo Ryan, Montse Ruiz, María de Carranza, et al. (+5)
76 [GO] 2021―Mar―31 Correction to: Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia Emily McKemey, Adrian M. Shields, Sian E. Faustini, Harriet J. Hill, Aliaksandra Baranskaya, Zania Stamataki, et al. (+4)
77 [GO] 2021―Mar―25 Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2 Paul Bastard, Romain Lévy, Soledad Henriquez, Christine Bodemer, Tali-Anne Szwebel, Jean-Laurent Casanova
78 [GO] 2021―Mar―16 Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses Jennifer Hicks, Carleen Klumpp-Thomas, Heather Kalish, Anandakumar Shunmugavel, Jennifer Mehalko, John-Paul Denson, et al. (+8)
79 [GO] 2021―Feb―22 Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia Nicolas de Prost, Paul Bastard, Romain Arrestier, Slim Fourati, Mathieu Mahévas, Sonia Burrel, et al. (+9)
80 [GO] 2021―Feb―21 Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia Emily McKemey, Adrian M. Shields, Sian E. Faustini, Harriet J. Hill, Aliaksandra Barnskaya, Zania Stamataki, et al. (+4)
81 [GO] 2021―Feb―08 A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma Aled Iaboni, Natalie Wong, Stephen D. Betschel
82 [GO] 2021―Jan―21 C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19 T. M. Ayodele Adesanya, Courtney M. Campbell, Lijun Cheng, Princess U. Ogbogu, Rami Kahwash
83 [GO] 2021―Jan―20 Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 Romain Lévy, Paul Bastard, Fanny Lanternier, Marc Lecuit, Shen-Ying Zhang, Jean-Laurent Casanova
84 [GO] 2021―Jan―18 Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19 Veronica Azmy, Kelsey Kaman, Daiwei Tang, Hongyu Zhao, Charles Dela Cruz, Jeffrey E. Topal, et al. (+2)
85 [GO] 2021―Jan―15 The Impact of the SARS-CoV-2 Pandemic in PID Patients Receiving Ig Replacement Therapy Sukru Cekic, Fatih Cicek, Sara Sebnem Kilic
86 [GO] 2021―Jan―04 Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France Julie Toubiana, Jérémie F. Cohen, Joséphine Brice, Clément Poirault, Fanny Bajolle, William Curtis, et al. (+7)
87 [GO] 2021―Jan―03 IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 Romain Lévy, Paul Bastard, Fanny Lanternier, Marc Lecuit, Shen-Ying Zhang, Jean-Laurent Casanova
88 [GO] 2021―Jan―02 SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage Florian Reizine, Mathieu Lesouhaitier, Murielle Gregoire, Kieran Pinceaux, Arnaud Gacouin, Adel Maamar, et al. (+22)
89 [GO] 2020―Dec―01 Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency Samaneh Delavari, Hassan Abolhassani, Farhad Abolnezhadian, Fateme Babaha, Sara Iranparast, Hamid Ahanchian, et al. (+23)
90 [GO] 2020―Nov―27 N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects Cristiane J. Nunes-Santos, Hye Sun Kuehn, Sergio D. Rosenzweig
91 [GO] 2020―Nov―26 A Case-Control Study of the 2019 Influenza Vaccine and Incidence of COVID-19 Among Healthcare Workers Nilofar Massoudi, Babak Mohit
92 [GO] 2020―Nov―24 The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19 Enric Monreal, Susana Sainz de la Maza, Jose Ignacio Fernández-Velasco, Elena Natera-Villalba, Claudia Geraldine Rita, Fernando Rodríguez-Jorge, et al. (+14)
93 [GO] 2020―Nov―20 Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy Jonathan London, David Boutboul, Karine Lacombe, France Pirenne, Beate Heym, Valérie Zeller, et al. (+3)
94 [GO] 2020―Nov―14 Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis Mathilde Roumier, Romain Paule, Alexandre Vallée, Julien Rohmer, Marie Ballester, Anne-Laure Brun, et al. (+22)
95 [GO] 2020―Oct―31 Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis Wanvisa Udomsinprasert, Jiraphun Jittikoon, Sermsiri Sangroongruangsri, Usa Chaikledkaew
96 [GO] 2020―Oct―27 Recovery from COVID-19 in a Child with Chronic Granulomatous Disease and T Cell Lymphopenia Vasudha Mantravadi, Suong T. Nguyen, S. Celeste Morley, Jeffrey J. Bednarski, Maleewan Kitcharoensakkul, Megan A. Cooper
97 [GO] 2020―Aug―22 Unraveling the Immune Response in Severe COVID-19 Lucie Rodriguez, Petter Brodin
98 [GO] 2020―Aug―22 Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome Lila Bouadma, Aurélie Wiedemann, Juliette Patrier, Mathieu Surénaud, Paul-Henri Wicky, Emile Foucat, et al. (+8)
99 [GO] 2020―Jul―13 Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection Ying Luo, Liyan Mao, Xu Yuan, Ying Xue, Qun Lin, Guoxing Tang, et al. (+3)
100 [GO] 2020―Jul―10 Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm Shima Mahmoudi, Mitra Rezaei, Nahal Mansouri, Majid Marjani, Davood Mansouri
101 [GO] 2020―Jun―28 Flow Cytometry Identifies Risk Factors and Dynamic Changes in Patients with COVID-19 Daniele Moratto, Marco Chiarini, Viviana Giustini, Federico Serana, Paola Magro, Aldo Maria Roccaro, et al. (+4)
 [1] 

101 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec